Mayo Clinic Cancer Center’s Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI) for prostate cancer research has been renewed for an additional five years. SPORE grants are highly competitive awards given to institutions on the cutting edge of translational research in specific types of cancer.
The Mayo Clinic Nicotine Research Program is conducting a research study to help smokers who would like to quit. The study will test whether the drug Chantix (varenicline) helps smokers who have Chronic Obstructive Pulmonary Disease (COPD) stop smoking.
Exposure to industrial chemicals in the womb or early in life can impair brain development but only a handful are controlled to protect children, researchers said on Wednesday.
A special research program at St. Joseph’s Hospital and Medical Center is providing a safe and vital research component to scientists in hopes of finding new treatments and cures for a variety of disorders.
Center neurologist shows that brain injury may occur within one millisecond after a human head is thrust into a windshield in a car accident. This happens before any overall motion of the head following impact with the windshield and is a new concept to consider for doctors interested in traumatic brain injury.
For the first time, scientists at the Max Planck Institute for Neurobiology in Martinsried near Munich have been able to show how two nerve cells communicate with each other from different hemispheres in the visual center. This astoundingly simple circuit diagram could at a later date provide a model for algorithms to be deployed in technical systems (Nature Neuroscience, Oct. 10, 2006).
Antioxidant-based pain killers may one day become a viable alternative to addictive medications such as morphine. Researchers found that synthetic antioxidants practically eradicated pain-like behavior in nearly three-quarters of mice with inflamed hind paws.
A gene variant associated with mental illness goes hand-in-hand with enlargement of a brain region that handles negative emotions, researchers at UT Southwestern Medical Center and the Central Texas Veterans Health Care System have found.
Royal Philips (NYSE: PHG, AEX: PHI) is introducing advances in its portfolio of leading oncology solutions to help physicians define their targets easily and effectively. Recognizing that console time is at a premium in busy imaging centers, Philips is announcing the availability of its Tumor LOC application on the workstation. The company is also unveiling Panorama 1.0T R/T?the first high field open MR simulator. These technologies are on display at the 48th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Philadelphia.
UT Southwestern Medical Center, UT Dallas’ Center for BrainHealth and Shelton School of Dallas will join forces to conduct an innovative three-year research study aimed at helping children with attention deficit hyperactivity disorder and their families.